APPLICATION
BLA761322
TYPE
BLA
ORIGINAL APPROVAL
2023-08-24
LATEST ACTION
2026-07-23
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
TYRUKOPrescription
NATALIZUMAB-SZTN 300MG/15ML(20MG/ML) · INJECTABLE · INJECTION
Approval history
2026-02-02REMS · Supplement 7AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.